Li, M., Li, Q., Zhang, Y., Xu, C., Chen, Z., Huang, Y., Jiang, L. (2025). Cost-effectiveness of polatuzumab vedotin plus chemoimmunotherapy for untreated diffuse large B-cell lymphoma in China. Scientific Reports. https://doi.org/10.1038/s41598-025-15477-9